1. NEW PSYCHOACTIVE SUBSTANCES (NPS) AND HARM REDUCTION
Grzegorz Wodowski
Drop-in Center MONAR - KRAKOW

2. OVERVIEW OF THREE MAIN GROUPS OF NPS
Stimulants (cathinones).
Synthetic cannabinoids.
Synthetic opioids.

3. HOW NPS ARE REPLACING TRADITIONAL DRUGS (TD)
Criminalization vs legality.
Low quality of TD.
Easy access to NPS.
No contact with dealers.
More diversity.
No positive tests of urine.
Drug users opinions about NPS.

4. APPROACH TO NPS Media scare. Criminalization and cat-mouse game.
No action in the field of harm reduction for consumers of NPS.
Information gap between science and practice (lack of proper knowledge). Risks related to NPS use among PUDH.

5. DIFFERENT FACES OF NPS MARKET
Legal/grey smart shops.
Internet market.
Local adds and deliveries.
Black market.

6. RISK RELATED TO VARIOUS NPS USE
Psychiatric disorders.
Social consequences associated with intoxication.
Physical health harms.

7. TD WITH A RELATIVELY LOW RISK OF USE AND MORE DANGEROUS NPS
Marihuana vs. synthetic cannabinoids.

8. HR INTERVENTION (BASED OF MONAR-KRAKOW IMPLEMENTATION)
Contacts with people using NPS.
Educational work with PUDH (written materials, web-sites).
Needle exchange.
Trainings for staff.
Other intervention: (e.g. “daily” shelter, cooperation with the local mental services/hospital).

9. CHALLENGES OST patients and NPS.
Encouraging for more rational public discussion and better perception of NPS problem.
Increase effectiveness of early warning system.